欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/0299/001
药品名称Xusal
活性成分
    • Levocetirizine dihydrochloride 5.0 mg
剂型Film-coated tablet
上市许可持有人UCB Pharma GmbH Alfred-Nobel-Str. 10 40789 Monheim Germany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Xyzall 5 mg Filmtabletten
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Xyzal
    • Latvia (LV)
    • Lithuania (LT)
      Xyzal 5mg plėvele dengtos tabletės
    • Estonia (EE)
      XYZAL
    • Hungary (HU)
      Xyzal 5mg
    • Cyprus (CY)
    • Czechia (CZ)
    • Slovakia (SK)
      Xyzal
    • Slovenia (SI)
    • Malta (MT)
许可日期2001/08/16
最近更新日期2025/01/27
药物ATC编码
    • R06AE09 levocetirizine
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Article 4.8 Di 65/65
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase